newsfilter
← Latest News
Business Wire·

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

EQ

Combination of IL-15 and IL-21 robustly augments NK and CD8 T cell activity Equillium Inc. (NASDAQ:EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel